Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 102,954	$ 89,581
Accounts receivable, net	44,930	33,761
Inventories	52,501	72,501
Prepaid expenses and other current assets	5,564	6,590
Total current assets	205,949	202,433
Operating lease right-of-use asset	6,467	11,351
Property and equipment, net	7,729	7,477
Goodwill	2,269	2,269
Intangible assets, net	110	162
Deferred tax assets, net	89,426	0
Other assets	733	1,715
Total assets	312,683	225,407
Current liabilities
Accounts payable	16,332	15,134
Accrued expenses	32,010	35,685
Total current liabilities	48,342	50,819
Long term liabilities
Operating lease liabilities, net of current portion	1,325	4,919
Total liabilities	49,667	55,738
Commitments and contingencies (Note 7)
Stockholders’ equity
Preferred stock, $0.0001 par value, 20,000,000 shares authorized at September 30, 2026 and December 31, 2025, none issued or outstanding as of September 30, 2026 and December 31, 2025	0	0
Common stock, $0.0001 par value, 1,000,000,000 shares authorized at September 30, 2026 and December 31, 2025; 116,694,683 and 112,809,637 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively	12	11
Treasury stock, at cost, 7,214,231 and 0 shares as of September 30, 2026 and December 31, 2025, respectively	(25,240)	0
Additional paid-in capital	687,158	670,536
Accumulated deficit	(398,914)	(500,878)
Total stockholders’ equity	263,016	169,669
Total liabilities and stockholders’ equity	$ 312,683	$ 225,407